NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Haemolysis as an interference factor in clinical chemistry.

Author(s): Sonntag O

Publication: J Clin Chem Clin Biochem, 1986, Vol. 24, Page 127-39

PubMed ID: 3711797 PubMed Review Paper? No

Suggested by: ISBER


Purpose of Paper

The purpose of this paper was to ascertain the effects of specimen haemolysis on measurement of clinical chemistry analytes in blood.

Conclusion of Paper

The addition of haemolysed blood to serum resulted in decreased alkaline phosphatase, cholesterol, bilirubin, gamma-glutamyltransferase, albumin (by 1D gel only), and alpha-2-globulin levels, and increased aspartate aminotransferase, alanine aminotransferase, creatinine kinase, acid phosphatase, beta-globin, potassium and lactate dehydrogenase levels.

Studies

  1. Study Purpose

    The purpose of this study was to ascertain the effects of specimen haemolysis on measurement of clinical chemistry analytes in serum specimens. An aliquot of blood was haemolysed by freezing for 20 minutes at -40 degrees C, after which time it was mixed with the remainder of the clotted specimen and centrifuged and filtered to obtain serum without sediment.

    Summary of Findings:

    The addition of 0.8 g/L hemoglobin to serum resulted in decreased alkaline phosphatase, cholesterol, bilirubin and alpha-2-globulin and increased beta-globin, potassium and lactate dehydrogenase. The addition of 1.7 g/L or more of hemoglobin decreased gamma-glutamyltransferase and increased aspartate aminotransferase and acid phosphatase. Creatinine kinase increased when more than 2.5 g/L of hemoglobin was added and alanine aminotransferase increased. Albumin decreased (by 1D gel only) when more than 3.4 g/L hemoglobin was added. Specimen hemolysis had no clinically significant effects on the measurement of alpha-amylase, calcium, cholinesterase, chloride, cholesterol, creatinine, iron, glutamate dehydrogenase, alpha 1-globulin, gamma-globulin, glucose, uric acid, urea, sodium, phosphate, transferrin or triglycerides.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Carbohydrate Clinical chemistry/auto analyzer
    Protein Clinical chemistry/auto analyzer
    Small molecule Clinical chemistry/auto analyzer
    Electrolyte/Metal Clinical chemistry/auto analyzer
    Lipid Clinical chemistry/auto analyzer
    Glycoprotein Clinical chemistry/auto analyzer
    Protein 1D/2D gels
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Biospecimen components 0.8 g/L hemoglobin
    1.7 g/L hemoglobin
    2.5 g/L hemoglobin
    3.4 g/L hemoglobin
    4.2 g/L hemoglobin
    5.0 g/L hemoglobin
    5.8 g/L hemoglobin
    6.6 g/L hemoglobin
    Biospecimen Aliquots and Components Hemolysis Freeze/thaw-induced
    Hemolysate added
    No hemolysate added

You Recently Viewed  

News and Announcements

  • 2025’s Most Popular SOPs: See What Users Downloaded Most

  • Improving RNAseq Analysis of Small Biospecimens: New Recommendations Available

  • 2026 NCI Best Practices for Biospecimen Resources is Now Available!

  • More...